Global CDMO for Small Molecule API. AGC Pharma Chemicals, based in Barcelona and Japan, is a company specializing in the development and contract manufacturing of Active Pharmaceutical Ingredients, Small Molecule APIs, and advanced intermediates. We are part of the AGC Group, headquartered in Japan, and we offer an integrated supply chain, with globally coordinated capabilities in Europe and Asia, combined with a strong local presence in Barcelona. This structure allows us to ensure continuity, reliability, and long-term alignment with the needs of our pharmaceutical clients and support projects from the early development stages through to commercial production.

Innovamed Spain S.L. es una CMO especializada en inyección de plásticos en sala blanca ISO 7 que convierte ideas de dispositivos médicos en productos reales, listos para su industrialización y producción a escala.

Inteplast Medical, a division of Inteplast S.A., specializes in the design and manufacture of high-quality plastic solutions for the medical, pharmaceutical, and veterinary sectors. With over 50 years of experience and facilities in Spain and the Czech Republic, we operate a 1,500 m² ISO Class 8 clean room in Catalonia. Our capabilities include thermoplastic injection molding, overmoulding, bi-material injection, and final product assembly. Production is carried out under a sanitary license validated by AEMPS. We offer integrated, customized solutions, supporting our clients from concept to industrialization while ensuring compliance with the highest technical and regulatory standards.

Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of approximately 18,500 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market. We support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation.

Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from lifesaving and life-enhancing treatments. In Advanced Synthesis, we apply more than 125 years’ expertise in classic and complex chemistry to the manufacturing of small molecules, highly potent APIs, antibody-drug conjugates and bioconjugates. 

We are a vertically integrated pharmaceutical company. We specialize in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Our portfolio includes approximately 45 APIs and 20 FDFs, we offer contract development and manufacturing (CDMO) and we are global leaders in chlorhexidine products. 

With over half a century of industry experience, and as a recently certified B Corp, we guarantee the highest standards of quality, operational excellence, and respect for the environment.

CDMO specilized in small molecules with 7 manufacturing sites and 2 R&D Centers, all located in Europe.

Moehs can cover the full lifecycle of the molecule, starting in pre-clinical, clinical phases and comercial launch.

Nanomol Technologies is both a Drug Delivery and a GMP certified Contract Analysis partner for pharmaceutical and biotech industries.

Our DELOS nanoformulation technology enables the development of  value-added medicines with enhanced efficacy, selectivity and reduced side-effects.

We provide value to companies who require appropriate characterization of critical quality attributes such as particle size, morphology and structural properties of both drug substance and drug products.

Prasfarma is a CMO/CDMO specialized in the development and GMP manufacturing of high-potency and oncology products, with a strong focus on sterile injectable and lyophilized formulations.

We provide end-to-end support from early clinical stages to commercial supply, operating under EU GMP Annex 1 standards with advanced isolator technology.

Our approach combines flexibility, technical expertise, and innovation to support complex pharmaceutical projects.

RidNova is a biopharmaceutical company dedicated to addressing health challenges and driving innovation in pharmaceuticals, biosimilars, and biologics, to improve patient outcomes. We specialise in formulation development, formulation consulting, analytical and commercial manufacturing, leveraging state-of-the-art technologies and extensive industry expertise. We offer comprehensive product and dossier development and formulation, regulatory & CMC consultancy, advisory services in complex formulation, biosimilars, biologicals, 505 b (2)/hybrid, differentiated, innovative, value-added formulations to Pharma, CDMO, small biotech/startups for formulation, as well as guidance on regulatory strategy. RidNova also provides services in IP, regulatory submissions, post-launch activities and strategic publication planning to support the successful introduction and positioning of pharmaceutical assets in the market.